β-Blocker Therapy in Heart Failure
Authors:
- Michael H. FarrellMFMichael H. Farrell
- Harlan M. KrumholzHKHarlan M. Krumholz
Open Access
- 20 February 2002
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 287 (7) , 883-889
Abstract
A medication once thought to be dangerous1-3 for patients with heart failure, β-blockers have been shown to reduce morbidity and mortality4-9 and are strongly supported by consensus recommendations and clinical guidelines.10-12 Clinicians are now challenged to translate this important new information into clinical practice.Keywords
This publication has 3 references indexed in Scilit:
- Mechanism of Action of Beta-Blocking Agents in Heart FailureThe American Journal of Cardiology, 1997
- Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureCirculation, 1996
- Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.Circulation, 1994